{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:30:29Z","timestamp":1792024229240,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.sapharm.2024.05.006","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:53:17Z","timestamp":1716486797000},"page":"905-910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A comparative analysis of medication counting methods to assess polypharmacy in medico-administrative databases"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0261-0879","authenticated-orcid":false,"given":"Marie-Eve","family":"Gagnon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miceline","family":"M\u00e9sidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann M.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Gosselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Candas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3294-7883","authenticated-orcid":false,"given":"Caroline","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2024.05.006_bib1","series-title":"Technical Series on Safer Primary Care: Multimorbidity","year":"2016"},{"key":"10.1016\/j.sapharm.2024.05.006_bib2","series-title":"Medication Safety in Polypharmacy","year":"2019"},{"issue":"10","key":"10.1016\/j.sapharm.2024.05.006_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","article-title":"The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish prescribed drug register","volume":"30","author":"Johnell","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.sapharm.2024.05.006_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h949","article-title":"Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines","volume":"350","author":"Dumbreck","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.sapharm.2024.05.006_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5455\/msm.2016.28.129-132","article-title":"Medication adherence in elderly with polypharmacy living at home: a systematic review of existing studies","volume":"28","author":"Zelko","year":"2016","journal-title":"Mater Sociomed"},{"issue":"1","key":"10.1016\/j.sapharm.2024.05.006_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expet Opin Drug Saf"},{"key":"10.1016\/j.sapharm.2024.05.006_bib7","first-page":"1","article-title":"d\u00e9finitions, mesures et enjeux","volume":"204","author":"Mon\u00e9gat","year":"2014","journal-title":"Questions d\u2019\u00e9conomie de la sant\u00e9"},{"issue":"3","key":"10.1016\/j.sapharm.2024.05.006_bib8","first-page":"e285","article-title":"La polypharmacie: enjeux m\u00e9thodologiques \u00e0 consid\u00e9rer","volume":"22","author":"Sirois","year":"2015","journal-title":"J Popul Ther Clin Pharmacol."},{"issue":"3","key":"10.1016\/j.sapharm.2024.05.006_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jgs.15717","article-title":"How chronic is polypharmacy in old age? A longitudinal nationwide cohort study","volume":"67","author":"Wastesson","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2024.05.006_bib10","series-title":"Prescription Drug Use Among Adults Aged 40\u201379 in the United States and Canada","author":"Hales Cms","year":"2019"},{"issue":"3","key":"10.1016\/j.sapharm.2024.05.006_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214240","article-title":"Trends in polypharmacy and dispensed drugs among adults in The Netherlands as compared to the United States","volume":"14","author":"Oktora","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.sapharm.2024.05.006_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008656","article-title":"Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study","volume":"5","author":"Moriarty","year":"2015","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.sapharm.2024.05.006_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/pds.3938","article-title":"Changes in clinical outcomes for community-dwelling older people exposed to incident chronic polypharmacy: a comparison between 2001 and 2009","volume":"25","author":"Franchi","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2024.05.006_bib14","series-title":"Drug Use Among Seniors in Canada, 2016","year":"2018"},{"key":"10.1016\/j.sapharm.2024.05.006_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.rcsop.2021.100053","article-title":"Polypharmacy trajectories among older women with and without dementia: a longitudinal cohort study","volume":"3","author":"Thapaliya","year":"2021","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"key":"10.1016\/j.sapharm.2024.05.006_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2023.105100","article-title":"Medication overload: a closer look at polypharmacy and potentially inappropriate medications among older people in Taiwan and Japan","volume":"115","author":"Meng","year":"2023","journal-title":"Arch Gerontol Geriatr"},{"issue":"4","key":"10.1016\/j.sapharm.2024.05.006_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.24095\/hpcdp.34.4.06","article-title":"Quebec integrated chronic disease surveillance System (QICDSS), an innovative approach","volume":"34","author":"Blais","year":"2014","journal-title":"Chronic Dis Inj Can"},{"issue":"1","key":"10.1016\/j.sapharm.2024.05.006_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jebm.12593","article-title":"Polypharmacy and risk of fractures in older adults: a systematic review","volume":"17","author":"Gagnon","year":"2024","journal-title":"J Evid Base Med"},{"key":"10.1016\/j.sapharm.2024.05.006_bib20","series-title":"Calculate Several Polypharmacy Indicators. 1.0.0 Ed","author":"Boucher","year":"2022"},{"issue":"1","key":"10.1016\/j.sapharm.2024.05.006_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"issue":"4","key":"10.1016\/j.sapharm.2024.05.006_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.24095\/hpcdp.29.4.05","article-title":"A deprivation index for health planning in Canada","volume":"29","author":"Pampalon","year":"2009","journal-title":"Chron Dis Can"},{"issue":"5","key":"10.1016\/j.sapharm.2024.05.006_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MLR.0000000000000905","article-title":"Validation of the combined comorbidity index of Charlson and elixhauser to predict 30-day mortality across ICD-9 and ICD-10","volume":"56","author":"Simard","year":"2018","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.sapharm.2024.05.006_bib24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med"},{"issue":"2","key":"10.1016\/j.sapharm.2024.05.006_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pds.966","article-title":"Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database","volume":"14","author":"Fincke","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.sapharm.2024.05.006_bib26","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1128\/AAC.02239-13","article-title":"Trends and seasonal variation in outpatient antibiotic prescription rates in the United States, 2006 to 2010","volume":"58","author":"Suda","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.sapharm.2024.05.006_bib27","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1080\/02770903.2017.1362426","article-title":"Seasonal patterns of Asthma medication fills among diverse populations of the United States","volume":"55","author":"Turi","year":"2018","journal-title":"J Asthma"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112400175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112400175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T21:48:09Z","timestamp":1722462489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155174112400175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S155174112400175X"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.05.006","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative analysis of medication counting methods to assess polypharmacy in medico-administrative databases","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}